« Back to Record
Citation APA

Venet, D., Rothé, F., Dupont, F., Maetens, M. M., Fumagalli, D., Salgado, R., Bradbury, I., Pusztai, L., Harbeck, N., Izquierdo, M., de la Peña, L., Ignatiadis, M., de Azambuja, E., Huober, J., Nuciforo, P., Baselga, J., Piccart-Gebhart, M., Loi, S., & Sotiriou, C. (2017). Deregulation of A-to-I RNA editing is associated with poor prognosis in HER2+ breast cancers in the neoALTTO trial. Poster session presented at 40th San Antonio Breast Cancer Symposium (40: 05-09/12/2017: San Antonio, TX, USA).


Permalink

http://hdl.handle.net/2013/ULB-DIPOT:oai:dipot.ulb.ac.be:2013/265815

Venet, D., Rothé, F., Dupont, F., Maetens, M. M., Fumagalli, D., Salgado, R., Bradbury, I., Pusztai, L., Harbeck, N., Izquierdo, M., de la Peña, L., Ignatiadis, M., de Azambuja, E., Huober, J., Nuciforo, P., Baselga, J., Piccart-Gebhart, M., Loi, S., & Sotiriou, C. (2017). Deregulation of A-to-I RNA editing is associated with poor prognosis in HER2+ breast cancers in the neoALTTO trial. Poster session presented at 40th San Antonio Breast Cancer Symposium (40: 05-09/12/2017: San Antonio, TX, USA).